OrbusNeich Medical Group Holdings Limited (Q8T.F)

0.5100 +0.0180 (+3.66%) At close: 11:41AM CEST

OrbusNeich Medical Group Holdings Limited

Building 20E
3rd Floor Units 303 & 305 Hong Kong Science Park
Sha Tin
Hong Kong
852 2802 2288
https://orbusneich.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 1,249

Key executives

Name	Title	Pay	Exercised	Year born
Mr. David Chien	Chairman of the Board & CEO	938.78k	N/A	1965
Mr. Wing Shing Chen	CFO, Company Secretary & Executive Director	527.83k	N/A	1982
Ms. Kwai Ching Lau	COO & Executive Director	651.21k	N/A	1975
Mr. Robert John Cottone	Chief Technical Officer	N/A	N/A	1964
Mr. Alain Djamel Khair	Chief Commercial Officer	N/A	N/A	1971

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

OrbusNeich Medical Group Holdings Limited, an investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as sirolimus-eluting coronary stents, peripheral self-expandable stents, and paclitaxel-coated PTCA and PTA balloons. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.

Corporate governance

OrbusNeich Medical Group Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.